First Monday
Jobs
Jobs open to youOnly jobs that can hire where you liveA CV for each jobWritten from your record, every line checkedMemoryIt remembers, so you don’t repeat yourselfInterview helpResearch, prep and hints only you seeWatch how it works0:28
FAQDocsUse in AI, Free
Your countryNorth AmericaEuropeAsia-PacificLatin AmericaNot on the list? Tell us where you liveRequest early accessEarly access
First Monday

Remote jobs that can actually hire you.

One email to confirm your address, and another when your group is invited. Free during the beta. By requesting access you agree to the Terms & Conditions and the Privacy Policy.

Beta formacOSWindows

Jobs

Jobs open to you in CanadaRemote jobs in the USRemote jobs in PolandRemote jobs in the UKRemote jobs in CanadaRemote jobs in Mexico

Product

Jobs open to youA CV for each jobMemoryInterview helpHow it works

Company

FAQContact

Legal

Privacy PolicyTerms & Conditions
Jobs
Jobs open to you in CanadaRemote jobs in the USRemote jobs in PolandRemote jobs in the UKRemote jobs in CanadaRemote jobs in Mexico
Product
Jobs open to youA CV for each jobMemoryInterview helpHow it works
Company
FAQContact
Legal
Privacy PolicyTerms & Conditions
Remote jobs by country
United StatesPolandUnited KingdomCanadaMexicoBrazilGermanySpainPortugalIrelandNetherlandsIndiaSwedenBelgiumAustriaDenmarkFinlandSwitzerlandNorwayAustraliaNew Zealand

Remote jobs by country

United StatesPolandUnited KingdomCanadaMexicoBrazilGermanySpainPortugalIrelandNetherlandsIndiaSwedenBelgiumAustriaDenmarkFinlandSwitzerlandNorwayAustraliaNew Zealand
© 2026 First MondayNo tracking cookies. Anonymous page statistics only.
First Monday
Jobs/Healthcare/Associate Director, Drug Substance, Pulmovant

Associate Director, Drug Substance, Pulmovant

Pulmovant

Remote · USHealthcarePosted September 24, 2026
Open to people in the United StatesApply for this job Write my CV for this job Early access
Pay
Not stated
Required
ssNMR, XRPD, Quality by Design (QbD), ICH M7
Nice to have
inhaled/inhalation products
Reports to
Sr. Director of Drug Substance Development
Experience
8+ years
Posted
September 24, 2026
Company
Pulmovant

Who it can hire

We read the post for each of the 21 countries we cover.

  • Open to people in the US

    The employer lists this job as remote there: “Remote, US”.

  • Not open to people in the other 20 countries we cover, as far as the post says.

The job post

Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 3 PHrontier global clinical trial in PH-ILD, but with potential broad applicability across the PH and ILD disease landscape.

Pulmovant recently announced positive results from its Phase 2 PHocus study evaluating mosliciguat for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), a progressive and life-threatening condition with significant unmet medical needs for patients. PHocus met both primary and secondary endpoints including the highest ever reported pulmonary vascular resistance (PVR) reduction in any randomized controlled PH trial. The robust results, in conjunction with mosliciguat’s once-daily, inhaled administration and potential first-in-class sGC activator profile, strongly position it as a potential single agent treatment and combination therapy for patients with PH-ILD. These data represent a significant advancement in a devastating disease that affects ~200,000 patients with no or very limited treatment options. A Phase 3 trial is currently underway. More details can be found in the press release here.

As part of the Roivant family of companies, Pulmovant leverages the power of collaboration and innovation to drive progress.

For more information, please visit https://www.pulmovant.com.

About Roivant:

Roivant specializes in developing transformative medicines at an accelerated pace through the launch of nimble biopharmaceutical and health technology entities, each meticulously tailored to address a specific medical need. Since its inception in 2014, Roivant has achieved the following critical milestones in support of its vision: built over 20 Vants; 12 consecutive positive Phase 3 trials; 9 FDA approvals; 5 successful IPOs; >$6B in capital raised; >$10B in global pharma partnerships and proceeds; and continued pipeline expansion across various modalities and therapeutic areas through in-licensing and acquisition of novel product candidates and technology platforms. In addition to a robust clinical stage pipeline, Roivant also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.

Position: Associate Director, Drug Substance (Process Chemistry)

Summary:

Pulmovant is seeking a highly strategic Associate Director, Drug Substance (Process Chemistry) to drive the late-stage development, scale-up, and commercial manufacturing of our pipeline. Reporting directly to the Sr. Director of Drug Substance Development, this pivotal role bridges Phase 3 clinical supply with commercial readiness. The successful candidate will lead process design and tech transfer across our external CDMO network, applying rigorous Quality by Design (QbD) principles to ensure robust manufacturing and successful regulatory submissions.

KeyDuties and Responsibilities

  • Drug Substance Development:
    • Partner cross-functionally with internal CMC, Regulatory, and Quality teams to design, optimize, and define highly robust, scalable drug substance processes
    • Direct the optimization and scale-up of manufacturing processes at external partners
    • Embed Quality by Design (QbD) principles and systematic Design of Experiments (DoE) methodologies to establish Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) in preparation for Phase 3 and commercial filing
  • Technical Transfer and Scale-Up:
    • Spearhead the technical transfer of drug substance processes across global CDMOs, executing seamless, risk-mitigated transitions
    • Lead scale-up activities and process validation campaigns (PPQ) in strict alignment with FDA, EMA, and other major regulatory bodies
    • Oversee the implementation of commercial-scale manufacturing lines, ensuring process consistency, yield optimization, and long-term supply robustness
  • Regulatory and Quality Compliance:
    • Ensure all drug substance development and manufacturing activities strictly comply with global cGMP and regulatory standards
    • Establish comprehensive drug substance control strategies, including rigorous impurity profiling (mutagenic/nitrosamine impurities) and Proven Acceptable Ranges (PARs) per ICH guidelines
    • Support authoring and reviewing of CMC sections for global regulatory submissions (e.g., NDA Module 3) and help responding to agency inquiries

Education and Experience

  • Ph.D. or M.S. in Organic Chemistry, Chemical Engineering, Pharmaceutical Sciences, or a closely related discipline
  • 8+ years of progressive experience in small molecule drug substance development and manufacturing within the pharmaceutical industry, focusing on late-stage development and commercialization
  • Strong background in managing CDMO relationships and outsourcing strategies
  • Demonstrated experience in process development, scale-up, and technical transfer
  • Knowledge of global regulatory requirements and cGMP compliance
  • Excellent project management, organizational, and leadership skills
  • Ability to work in a fast-paced, cross-functional environment and influence internal and external stakeholders
  • In-depth knowledge of material sciences and solid-state characterization, including ssNMR, XRPD, and advanced spectroscopic techniques
  • Experience with inhaled/inhalation products is a plus

EssentialSkills andAbilities

  • Strong written and verbal communication skills, with a proven ability to present complex technical data clearly and interact effectively with regulatory authorities, global CDMOs, and senior corporate leadership
  • Proven, hands-on experience driving drug substance chemistry, manufacturing, and control (CMC) activities directly supporting a successful NDA submission
  • Prior experience preparing for, hosting, or managing a successful regulatory Pre-Approval Inspection (PAI)
  • Recognized Subject Matter Expert (SME) in late-stage process characterization, including Quality by Design (QbD), PAR/NOR establishment, Fate and Purge of impurities studies, and ICH M7/nitrosamine safety assessments
  • Highly fluent and well-versed in global ICH guidelines for drug substance development and manufacturing

Pulmovant provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.

We will not accept unsolicited resumes nor outreach from agencies. Please do not send agency resumes to our website or Roivant Sciences and affiliated employees. Thanks!

First Monday isn’t the employer or a recruiter and isn’t affiliated with Pulmovant. Details may have changed since; confirm with the employer before you apply.

Open to people in the United StatesApply for this job Write my CV for this job Early access
Pay
Not stated
Required
ssNMR, XRPD, Quality by Design (QbD), ICH M7
Nice to have
inhaled/inhalation products
Reports to
Sr. Director of Drug Substance Development
Experience
8+ years
Posted
September 24, 2026
Company
Pulmovant

Similar jobs open to people in the United States

Global Scientific Director – Liver DiseaseMirum Pharmaceuticals · Remote · USClinical Exercise Physiologist – Pulmonary RehabilitationKivo Health · Remote · USDirector/Sr. Director Clinical PharmacologyBridgeBio Pharma · Remote · USRegulatory Affairs CMC Associate IIIovance Biotherapeutics · Remote · US
First Monday

Get jobs like this every Monday.

One email a week with new remote jobs open to people in Canada. Free, and one click to unsubscribe. Privacy Policy

Or request early access to the app
Apply for this job